Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7
1 clinical trials · Condition
◉ Watch Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma (NCT03430687) | University of California, San Francisco | 2018-06-01 |
Track Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.